BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35846327)

  • 1. A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes.
    Kong WY; Liu ZA; Zhang N; Wu X; Zhao XB; Yan L
    Front Endocrinol (Lausanne); 2022; 13():849794. PubMed ID: 35846327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients.
    Zhou R; Yang Y; Lu Q; Wang J; Miao Y; Wang S; Wang Z; Zhao C; Wei L
    Gynecol Oncol; 2015 Dec; 139(3):424-8. PubMed ID: 26428941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia.
    Campo G; Rebecchi A; Vanni VS; Pagliardini L; Patruno C; Papaleo E; Candiani M; Giardina P
    Reprod Biomed Online; 2021 Nov; 43(5):864-870. PubMed ID: 34629315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study.
    Kjøtrød SB; Carlsen SM; Rasmussen PE; Holst-Larsen T; Mellembakken J; Thurin-Kjellberg A; Haapaniemikouru K; Morin-Papunen L; Humaidan P; Sunde A; von Düring V
    Hum Reprod; 2011 Aug; 26(8):2045-53. PubMed ID: 21606131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT.
    Li R; Mai T; Zheng S; Zhang Y
    Arch Gynecol Obstet; 2022 Nov; 306(5):1711-1721. PubMed ID: 35829765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and pregnancy outcomes of hysteroscopic surgery combined with progestin as fertility-sparing therapy in patients with early stage endometrial cancer and atypical hyperplasia.
    Xi Y; Liu G; Liu D; Jiang J; Gong R
    Arch Gynecol Obstet; 2023 Feb; 307(2):583-590. PubMed ID: 35674831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
    Ercan CM; Duru NK; Sakinci M; Alanbay I; Karasahin KE; Baser I
    Gynecol Endocrinol; 2010 Feb; 26(2):125-8. PubMed ID: 20074021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The long-term efficacy of metformin in megestrol acetate-based fertility-sparing treatment for patients with endometrial atypical hyperplasia and endometrioid endometrial cancer].
    Dong YT; Guan J; Yang BY; Yierfulati G; Xue Y; Chen XJ
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):729-735. PubMed ID: 38462352
    [No Abstract]   [Full Text] [Related]  

  • 9. A systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures.
    Huang X; Wang P; Tal R; Lv F; Li Y; Zhang X
    Int J Gynaecol Obstet; 2015 Nov; 131(2):111-6. PubMed ID: 26304048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.
    Acosta-Torres S; Murdock T; Matsuno R; Beavis AL; Stone RL; Wethington SL; Levinson K; Grumbine F; Ferriss JS; Tanner EJ; Fader AN
    Gynecol Oncol; 2020 May; 157(2):348-356. PubMed ID: 32085863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome.
    Wang L; Luo X; Wang Q; Lv Q; Wu P; Liu W; Chen X
    J Gynecol Oncol; 2021 Sep; 32(5):e70. PubMed ID: 34132069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
    Mahmoud SA; Zhang L; Jia C; Zang H
    J Reprod Med; 2016; 61(5-6):302-5. PubMed ID: 27424378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and prognosis of fertility-preserved hysteroscopic surgery combined with progesterone in the treatment of complex endometrial hyperplasia and early endometrial carcinoma.
    Xu Z; Tian Y; Fu J; Xu J; Bao D; Wang G
    J BUON; 2020; 25(3):1525-1533. PubMed ID: 32862600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.
    Palomba S; Falbo A; Battista L; Russo T; Venturella R; Tolino A; Orio F; Zullo F
    Am J Obstet Gynecol; 2010 Jun; 202(6):577.e1-8. PubMed ID: 20096821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of fertility-sparing therapy of patients with complex atypical hyperplasia and endometrial cancer].
    Morimoto C; Wang YQ; Zhou R; Wang JL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):936-942. PubMed ID: 36241236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
    Shafiee MN; Khan G; Ariffin R; Abu J; Chapman C; Deen S; Nunns D; Barrett DA; Seedhouse C; Atiomo W
    Gynecol Oncol; 2014 Jan; 132(1):248-53. PubMed ID: 24183733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.
    Shan W; Wang C; Zhang Z; Gu C; Ning C; Luo X; Zhou Q; Chen X
    J Gynecol Oncol; 2014 Jul; 25(3):214-20. PubMed ID: 25045434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology.
    Ushijima K; Tsuda N; Yamagami W; Mitsuhashi A; Mikami M; Yaegashi N; Enomoto T
    J Gynecol Oncol; 2023 May; 34(3):e38. PubMed ID: 36659833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
    Fan Y; Li X; Wang J; Wang Y; Tian L; Wang J
    Reprod Biol Endocrinol; 2021 Aug; 19(1):118. PubMed ID: 34344384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indication of metformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome: prospective comparative study of 63 cases].
    Boudhrâa K; Jellouli MA; Amri M; Farhat M; Torkhani F; Gara MF
    Tunis Med; 2010 May; 88(5):335-40. PubMed ID: 20517830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.